Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Notable Mergers and Acquisitions of the Day 01/22: (JNJ) (OMG) (T)/(ATNI) (BOX)
-
Notable Analyst Rating Changes 01/04: (JNJ) (ZQK) (AVP) Upgraded; (LULU) (MSFT) (ABT) Downgraded
-
Deutsche Bank Upgrades Johnson & Johnson (JNJ) to Buy; Well-Diversified and Positioned
-
StreetInsider.com's Stocks for an Obama Victory
-
StreetInsider.com Guide for Presidential Election Stocks
-
Deutsche Bank Defends Dendreon (DNDN) Despite Strong Zytiga Data; Maintains Buy
-
Deutsche Bank Maintains a 'Hold' on Johnson & Johnson (JNJ); Phase 3 Data for Zytiga Shows Meaningful Results
-
Dendreon (DNDN) Hit On Various Worries, Deutsche Bank Defends
-
Deutsche Bank Maintains a 'Buy' on Dendreon (DNDN): Buyers on Any Weakness
-
Deutsche Bank Cuts Price Target In MedTech
-
Notable Analyst Rating Changes 10/04: (AMR) (SODA) (PLCM) Upgraded; (MDR) (GMR) (GTIV) Downgraded
-
Notable Analyst Rating Changes 07/08: (TJX) (FTR) (WDC) Upgraded; (GOOG) (SOL) (WFR) Downgraded
-
Deutsche Bank Starts Johnson & Johnson (JNJ) at Hold; Some Upside But Mot Enough
-
Deutsche Bank on Medical Supply & Device Stocks: J&J (NYSE: JNJ) Exiting Stents; First in, First Out
-
Q1 Earnings Season to Begin April 11th as Alcoa (AA) Leads the Way
-
Canaccord Genuity Morning Coffee on Amgen (AMGN): We Applaud Their Decisiveness
-
Boson Scientific (BSX) Earnings Preview: Shares Fibrillated Through Q1, Look to Restore Rhythm (STJ, MDT, JNJ)
-
Deutsche Bank Downgrades Boston Scientific (BSX) to Hold; 2010 Looks to Be Year of Rebuilding
-
Deutsche Bank Sees Johnson & Johnson (JNJ) as Solid Long-Term Investment; Raises PT Ahead of Earnings
-
David Moenning's Daily State of the Markets: 4/20
-
Morning Movers 4/14: DNDN, DBRN, AIG, MGM, FSS, LVS Higher; TLB, SXL, MS, VCLK, OESX, PTRY Lower
-
David Moenning's Daily State of the Markets: 10/29
-
Morning Movers 10/29: Corning (GLW) Sinks On Results/Guidance; MGM (MGM) Up on Results/Financing
-
Notable Mergers and Acquisitions of the Day 10/28: HUN, JNJ, VNO/LXP
-
Deutsche Bank Downgrades Zimmer Holdings (ZMH) to Hold
-
David Moenning's Daily State of the Markets: 10/14
-
Deutsche Bank Says Buy BioMimetic (BMTI) on Weakness
